Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Biofinderon May 24, 2018 11:04pm
321 Views
Post# 28078971

RE:RE:Thanks for the email, I’ll answer your questions publicly

RE:RE:Thanks for the email, I’ll answer your questions publiclywhen all is said and done, I’m expecting a 10+ bagger on my investment At The Very MINIMUM... anything less would have been a waste of my time.

By EOY 2020 we should start to see some fireworks with the U.K allowing the sell of 4050 to Alstrom patients under their Early Access program.

After EOY 2020 it’s anyone’s guess where the sp will end up.

imo Ryplazim and 4050 are ground breaking drugs aka blockbusters.

cheers!


balain wrote: Bio, if I was going to go by your SP valuation, I would get out of this stock tomorrow morning. Assuming we don’t have your 5:1 reverse split, you are looking at $10/share. My average of near $2, just to get $10 twenty three years later would not be worth my time.

Hopefully I won’t be disappointed, or get to your target much before EOY 2022.
I’d be Ok with your target by mid year 2020, not a day later...

cheers and good luck

balain


Bullboard Posts